drugset / Trial / NCT01095926

Pharmacokinetic Study of Doxorubicin in Children With Cancer

NCT01095926 ↗

Phase 2 Completed 101 enrolled University Hospital Muenster
NaSingle-groupOpen-labelTreatment

Summary

Analyze pharmacokinetics of doxorubicin in children with cancer. Furthermore investigate the predictive role of troponin and natriuretic peptides for anthracycline-induced cardiotoxicity .

Timeline

Start
2010-05
Primary completion
2013-02
Completion
2013-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxorubicin Other / unclassified — —